Acute pulmonary insufficiency due to OKT3 therapy.
Büsing
M
M
Department of Surgery, University of Tübingen, FRG.
Mellert
J
J
Greger
B
B
Hopt
U T
UT
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D004386:Duodenum / Q000637:transplantation; D006084:Graft Rejection; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D008168:Lung / Q000473:pathology*; D016853:Muromonab-CD3; D016035:Pancreas Transplantation / Q000276:immunology; D011446:Prospective Studies; D012129:Respiratory Function Tests
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3